Featured Research

from universities, journals, and other organizations

Nuclear Magnetic Resonance Spectroscopy May Help Predict Effectiveness Of Cholesterol Medication

Date:
August 14, 2001
Source:
Northwestern University
Summary:
Researchers at Northwestern University Medical School, the Centers for Disease Control and North Carolina State University are using nuclear magnetic resonance (NMR) spectroscopy to identify which patients may benefit most from specific cholesterol-lowering medications.

CHICAGO --- Researchers at Northwestern University Medical School, the Centers for Disease Control and North Carolina State University are using nuclear magnetic resonance (NMR) spectroscopy to identify which patients may benefit most from specific cholesterol-lowering medications.

Related Articles


NMR spectroscopy uses radio waves to analyze the size and concentration of lipoproteins – the small spheres that carry cholesterol around the body and deposit it in various locations, such as the coronary arteries or the liver.

Results of this study may be especially important now that the new heart health guidelines are projecting that as many as 36 million Americans should be taking cholesterol-lowering drugs. However, research has shown that the cholesterol-lowering effects of these medications may vary according to the individual.

"By evaluating specific medications with the NMR technology, physicians will be better able to select cholesterol medications that will have optimal results for the patient depending on his or her lipoprotein size and concentration," explained Robert Rosenson, M.D., director of the Preventive Cardiology Center at Northwestern University Medical School and a cardiologist at Northwestern Memorial Hospital.

"Ultimately, this will help patients get effective and even life-saving help quicker, and reduce the cost often involved in switching therapies," Rosenson said.

In a study to be published in an upcoming issue of the journal Atherosclerosis, Rosenson and colleagues analyzed the effect of a particular cholesterol-lowering drug, pravastatin, over a six-month period in a group of 262 patients with high-risk heart disease. Paravastatin belongs to the popularly prescribed class of statins. Several million Americans currently are receiving statin therapy to lower cholesterol levels.

"In the past, we had thought that a simple lipid test [blood test] could show us how well a particular cholesterol-lowering medication was working. But by using this new technology -- which gives us significantly more data than a cursory lipid test -- we found the medication is suitable for a broader base of patients than originally thought," Rosenson said.

The researchers found, in contrast to findings from earlier studies, pravastatin was equally effective in lowering LDL cholesterol levels [bad cholesterol] in all patients regardless of the LDL size at the beginning of the study.

Study participants with small LDL particles gained at least as much benefit from the medication as those with large LDL. Results of the study showed reductions in the number of total and small LDL particles and increases in average LDL and HDL particle size. The NMR technology used in this study is also used as a diagnostic tool to identify people at greatest risk for developing heart disease. It was developed by LipoMed, Inc., Raleigh, N.C.

"Sadly, almost half of the people who have so-called ‘normal’ cholesterol levels actually go on to develop heart disease," explains Dr. Rosenson. "Millions of them will die from it," he adds. "The good news is that the new technology enables us to more accurately identify individuals at silent but lethal risk, and allows the physicians to select and begin treatments early on."


Story Source:

The above story is based on materials provided by Northwestern University. Note: Materials may be edited for content and length.


Cite This Page:

Northwestern University. "Nuclear Magnetic Resonance Spectroscopy May Help Predict Effectiveness Of Cholesterol Medication." ScienceDaily. ScienceDaily, 14 August 2001. <www.sciencedaily.com/releases/2001/08/010814063047.htm>.
Northwestern University. (2001, August 14). Nuclear Magnetic Resonance Spectroscopy May Help Predict Effectiveness Of Cholesterol Medication. ScienceDaily. Retrieved March 31, 2015 from www.sciencedaily.com/releases/2001/08/010814063047.htm
Northwestern University. "Nuclear Magnetic Resonance Spectroscopy May Help Predict Effectiveness Of Cholesterol Medication." ScienceDaily. www.sciencedaily.com/releases/2001/08/010814063047.htm (accessed March 31, 2015).

Share This


More From ScienceDaily



More Health & Medicine News

Tuesday, March 31, 2015

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Solitair Device Aims to Takes Guesswork out of Sun Safety

Solitair Device Aims to Takes Guesswork out of Sun Safety

Reuters - Innovations Video Online (Mar. 31, 2015) — The Solitair device aims to take the confusion out of how much sunlight we should expose our skin to. Small enough to be worn as a tie or hair clip, it monitors the user&apos;s sun exposure by taking into account their skin pigment, location and schedule. Matthew Stock reports. Video provided by Reuters
Powered by NewsLook.com
Soda, Salt and Sugar: The Next Generation of Taxes

Soda, Salt and Sugar: The Next Generation of Taxes

Washington Post (Mar. 30, 2015) — Denisa Livingston, a health advocate for the Dinι Community Advocacy Alliance, and the Post&apos;s Abby Phillip discuss efforts around the country to make unhealthy food choices hurt your wallet as much as your waistline. Video provided by Washington Post
Powered by NewsLook.com
UnitedHealth Buys Catamaran

UnitedHealth Buys Catamaran

Reuters - Business Video Online (Mar. 30, 2015) — The $12.8 billion merger will combine the U.S.&apos; third and fourth largest pharmacy benefit managers. Analysts say smaller PBMs could also merge. Fred Katayama reports. Video provided by Reuters
Powered by NewsLook.com
S. Leone in New Anti-Ebola Lockdown

S. Leone in New Anti-Ebola Lockdown

AFP (Mar. 28, 2015) — Sierra Leone imposed a three-day nationwide lockdown Friday for the second time in six months in a bid to prevent a resurgence of the deadly Ebola virus. Duration: 01:17 Video provided by AFP
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
 
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:  

Breaking News:

Strange & Offbeat Stories

 

Health & Medicine

Mind & Brain

Living & Well

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:  

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile iPhone Android Web
Follow Facebook Twitter Google+
Subscribe RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins